VSee Health, Inc. Income Tax Expense
VSee Health, Inc. (VSEE) reported Income Tax Expense of -$17.90 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-14
- VSee Health, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was -$17.90K, a 1135.82% decline year-over-year.
- VSee Health, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $23.74K, a 75.77% increase year-over-year.
- VSee Health, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$4.48K, a 116.80% decline year-over-year.
- VSee Health, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. income tax expense (benefit) for fiscal 2024 was -$1.64M, a 189.36% decline from fiscal 2023.
- VSee Health, Inc. income tax expense (benefit) for fiscal 2023 was $1.84M, a 881.97% increase from fiscal 2022.
- VSee Health, Inc. income tax expense (benefit) for fiscal 2022 was $187.22K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$17.90K 10-Q · filed 2026-08-14 | $5.26K 10-Q · filed 2026-08-14 | $1.35K derived: sum of 3 quarters · filed 2026-08-14 | $1.35K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $23.74K 10-Q · filed 2026-05-15 | $19.25K derived: sum of 2 quarters · filed 2026-05-15 | $19.25K derived: sum of 3 quarters · filed 2026-05-15 | $20.98K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$4.48K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-15 | -$4.48K derived: sum of 2 quarters · filed 2026-05-15 | -$2.76K derived: sum of 3 quarters · filed 2026-08-14 | $13.51K 10-Q · filed 2026-05-15 | $68.43K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $1.73K derived: sum of 2 quarters · filed 2026-08-14 | $17.99K 10-Q · filed 2025-11-14 | $41.92K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $1.73K 10-Q · filed 2026-08-14 | $4.48K 10-Q · filed 2025-10-15 | $15.23K 10-Q · filed 2026-08-14 | $17.99K 10-Q · filed 2025-10-15 | $41.92K derived: sum of 3 quarters · filed 2026-08-14 | $50.72K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $13.51K 10-Q · filed 2026-05-15 | $40.19K derived: sum of 2 quarters · filed 2026-05-15 | $48.99K derived: sum of 3 quarters · filed 2026-05-15 | -$1.63M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $26.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $35.49K derived: sum of 2 quarters · filed 2026-03-31 | -$1.64M derived: sum of 3 quarters · filed 2026-03-31 | -$1.64M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $8.80K 10-Q · filed 2025-11-14 | -$550.03K 10-Q · filed 2024-11-14 | -$1.67M derived: sum of 2 quarters · filed 2025-11-20 | -$1.67M 10-Q · filed 2025-11-14 | -$2.79M 10-Q · filed 2024-11-14 | $759.86K derived: sum of 4 quarters · filed 2025-11-20 | ||
| 2024-06-30 | -$1.68M 10-Q/A · filed 2025-11-20 | -$2.24M 10-Q · filed 2024-09-23 | -$1.68M 10-Q/A · filed 2025-11-20 | -$2.24M 10-Q · filed 2024-09-23 | $751.06K derived: sum of 3 quarters · filed 2025-11-20 | $517.34K derived: sum of 4 quarters · filed 2025-11-20 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-10-15 | $2.43M derived: sum of 2 quarters · filed 2025-10-15 | $2.20M derived: sum of 3 quarters · filed 2025-10-15 | $2.02M derived: sum of 4 quarters · filed 2025-10-15 | ||||
| 2023-12-31 | $2.43M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $2.20M derived: sum of 2 quarters · filed 2025-08-29 | $2.02M derived: sum of 3 quarters · filed 2025-08-29 | $1.84M 10-K/A · filed 2025-08-29 | ||||
| 2023-09-30 | -$233.72K 10-Q · filed 2024-11-14 | -$408.11K derived: sum of 2 quarters · filed 2024-11-14 | -$590.95K 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$174.40K 10-Q · filed 2024-09-23 | $0.00 10-Q · filed 2023-08-21 | -$357.24K 10-Q · filed 2024-09-23 | $0.00 10-Q · filed 2023-08-21 | ||||
| 2022-12-31 | $104.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $187.22K derived: sum of 2 quarters · filed 2024-04-12 | $187.22K derived: sum of 3 quarters · filed 2024-04-12 | $187.22K 10-K · filed 2024-04-12 | ||||
| 2022-09-30 | $83.03K 10-Q · filed 2023-11-20 | $83.03K derived: sum of 2 quarters · filed 2023-11-20 | $83.03K 10-Q · filed 2023-11-20 | |||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-21 | $0.00 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |